Cargando…

The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study

This study aimed to determine the estimated proportion of contraindications among women taking combined oral contraceptives (COCs) and to assess the risk factors associated with their contraindications. This study was cross-sectional. Reproductive-aged women (18–49 years) on any COCs between 2018 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Assiri, Ghadah A., Bannan, Douha F., Alshehri, Ghadah H., Alshyhani, Manal, Almatri, Walaa, Mahmoud, Mansour A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835169/
https://www.ncbi.nlm.nih.gov/pubmed/35162588
http://dx.doi.org/10.3390/ijerph19031567
_version_ 1784649363133300736
author Assiri, Ghadah A.
Bannan, Douha F.
Alshehri, Ghadah H.
Alshyhani, Manal
Almatri, Walaa
Mahmoud, Mansour A.
author_facet Assiri, Ghadah A.
Bannan, Douha F.
Alshehri, Ghadah H.
Alshyhani, Manal
Almatri, Walaa
Mahmoud, Mansour A.
author_sort Assiri, Ghadah A.
collection PubMed
description This study aimed to determine the estimated proportion of contraindications among women taking combined oral contraceptives (COCs) and to assess the risk factors associated with their contraindications. This study was cross-sectional. Reproductive-aged women (18–49 years) on any COCs between 2018 and 2020 were recruited from one obstetrics–gynaecology clinic in a university-affiliated hospital and were included. Contraindications were defined using the World Health Organization (WHO) Medical Eligibility Criteria (MEC) for Contraceptive Use. Data were collected from electronic medical records for all included women, as well as a standardised, pretested, structured survey for one-third of the women. In this cross-sectional study, 380 women using COCs were included. Their mean age was 31.645 ± 7.366 years. Among them, 131 (34.5%) participated via a survey and electronic records, while the other 249 (65.5%) participated via electronic records only. The majority of the participants had a Bachelor’s degree (59.0%) and were married (62.1%). The overall estimated proportion of patients with at least one contraindication to COCs according to category 3 (relative contraindications) or 4 (absolute contraindications) was 31.3% (95% CI 26.63–35.99). The most common contraindications observed were controlled hypertension, category 3 (12.1%); major surgery with prolonged immobilisation, category 4 (4.7%); migraine with aura at any age, category 4 (4.2%); breastfeeding from six weeks to less than six months postpartum, category 3 (4.0%); and diabetes mellitus with complications, category 4 (3.2%). Significant factors associated with contraindications to COCs were married women (OR 2.19, 95% CI 1.38–3.46), those aged 35 years or more (OR 2.33, 95% CI 1.49–3.66), and those with one or more live births (OR 2.19, 95% CI 1.38–3.46). Ensuring proper assessment prior to prescribing and considering alternatives suitable for long-term use among women taking an oral contraceptive regularly is recommended.
format Online
Article
Text
id pubmed-8835169
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88351692022-02-12 The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study Assiri, Ghadah A. Bannan, Douha F. Alshehri, Ghadah H. Alshyhani, Manal Almatri, Walaa Mahmoud, Mansour A. Int J Environ Res Public Health Article This study aimed to determine the estimated proportion of contraindications among women taking combined oral contraceptives (COCs) and to assess the risk factors associated with their contraindications. This study was cross-sectional. Reproductive-aged women (18–49 years) on any COCs between 2018 and 2020 were recruited from one obstetrics–gynaecology clinic in a university-affiliated hospital and were included. Contraindications were defined using the World Health Organization (WHO) Medical Eligibility Criteria (MEC) for Contraceptive Use. Data were collected from electronic medical records for all included women, as well as a standardised, pretested, structured survey for one-third of the women. In this cross-sectional study, 380 women using COCs were included. Their mean age was 31.645 ± 7.366 years. Among them, 131 (34.5%) participated via a survey and electronic records, while the other 249 (65.5%) participated via electronic records only. The majority of the participants had a Bachelor’s degree (59.0%) and were married (62.1%). The overall estimated proportion of patients with at least one contraindication to COCs according to category 3 (relative contraindications) or 4 (absolute contraindications) was 31.3% (95% CI 26.63–35.99). The most common contraindications observed were controlled hypertension, category 3 (12.1%); major surgery with prolonged immobilisation, category 4 (4.7%); migraine with aura at any age, category 4 (4.2%); breastfeeding from six weeks to less than six months postpartum, category 3 (4.0%); and diabetes mellitus with complications, category 4 (3.2%). Significant factors associated with contraindications to COCs were married women (OR 2.19, 95% CI 1.38–3.46), those aged 35 years or more (OR 2.33, 95% CI 1.49–3.66), and those with one or more live births (OR 2.19, 95% CI 1.38–3.46). Ensuring proper assessment prior to prescribing and considering alternatives suitable for long-term use among women taking an oral contraceptive regularly is recommended. MDPI 2022-01-29 /pmc/articles/PMC8835169/ /pubmed/35162588 http://dx.doi.org/10.3390/ijerph19031567 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Assiri, Ghadah A.
Bannan, Douha F.
Alshehri, Ghadah H.
Alshyhani, Manal
Almatri, Walaa
Mahmoud, Mansour A.
The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study
title The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study
title_full The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study
title_fullStr The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study
title_full_unstemmed The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study
title_short The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study
title_sort contraindications to combined oral contraceptives among reproductive-aged women in an obstetrics and gynaecology clinic: a single-centre cross-sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835169/
https://www.ncbi.nlm.nih.gov/pubmed/35162588
http://dx.doi.org/10.3390/ijerph19031567
work_keys_str_mv AT assirighadaha thecontraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy
AT bannandouhaf thecontraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy
AT alshehrighadahh thecontraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy
AT alshyhanimanal thecontraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy
AT almatriwalaa thecontraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy
AT mahmoudmansoura thecontraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy
AT assirighadaha contraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy
AT bannandouhaf contraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy
AT alshehrighadahh contraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy
AT alshyhanimanal contraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy
AT almatriwalaa contraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy
AT mahmoudmansoura contraindicationstocombinedoralcontraceptivesamongreproductiveagedwomeninanobstetricsandgynaecologyclinicasinglecentrecrosssectionalstudy